医疗物联网等解决方案
Search documents
股票行情快报:创业慧康(300451)12月12日主力资金净买入813.70万元
Sou Hu Cai Jing· 2025-12-12 13:37
Core Viewpoint - The stock of Chuangyue Huikang (300451) has shown a decline in both price and financial performance, indicating potential challenges ahead for the company in the software development industry [1][3]. Financial Performance - As of December 12, 2025, Chuangyue Huikang's stock closed at 4.81 yuan, down 0.41% with a trading volume of 235,200 shares and a total transaction value of 113 million yuan [1]. - For the first three quarters of 2025, the company's main revenue was 862 million yuan, a year-on-year decrease of 26.26%, and the net profit attributable to shareholders was -122 million yuan, a decline of 331.69% [3]. - In Q3 2025 alone, the company reported a single-quarter main revenue of 285 million yuan, down 35.5% year-on-year, and a net profit of -41.67 million yuan, a decrease of 264.2% [3]. Market Position and Ratios - Chuangyue Huikang's total market capitalization is 7.451 billion yuan, significantly lower than the software development industry average of 12.464 billion yuan, ranking 84th out of 195 companies [3]. - The company's price-to-earnings ratio (P/E) is -45.72, while the industry average is 120.73, indicating a negative earnings situation [3]. - The gross margin stands at 49.87%, which is above the industry average of 43.84%, ranking 73rd out of 195 [3]. Investment Sentiment - In the last 90 days, two institutions have rated the stock as a buy, with an average target price of 6.05 yuan [4]. - On December 12, 2025, the net inflow of main funds was 8.137 million yuan, accounting for 7.17% of the total transaction value, while retail investors saw a net outflow of 6.5297 million yuan, representing 5.75% of the total [1][2].
股票行情快报:创业慧康(300451)11月25日主力资金净卖出1137.92万元
Sou Hu Cai Jing· 2025-11-25 14:41
Core Viewpoint - The stock of Chuangye Huikang (300451) has shown a recent increase in price, but the company is facing significant financial challenges, including declining revenues and net profits [1][3]. Financial Performance - As of November 25, 2025, Chuangye Huikang's stock closed at 5.43 yuan, up 3.23% with a trading volume of 978,900 shares and a total transaction value of 535 million yuan [1]. - For the first three quarters of 2025, the company's main revenue was 862 million yuan, a year-on-year decrease of 26.26%, and the net profit attributable to shareholders was -122 million yuan, down 331.69% [3]. - In Q3 2025 alone, the company reported a main revenue of 285 million yuan, a decline of 35.5% year-on-year, and a net profit of -41.67 million yuan, down 264.2% [3]. Market Position and Ratios - Chuangye Huikang's total market value is 8.412 billion yuan, which is below the software development industry average of 12.944 billion yuan, ranking 79th out of 195 companies [3]. - The company's price-to-earnings ratio (P/E) is -51.62, while the industry average is 126.72, indicating a significant underperformance [3]. - The gross profit margin stands at 49.87%, higher than the industry average of 43.84%, ranking 73rd in the industry [3]. Investment Sentiment - In the last 90 days, three institutions have rated the stock as a buy, with an average target price of 5.76 yuan [4].
创业慧康(300451)新增【阿里】概念
Sou Hu Cai Jing· 2025-11-19 08:48
Group 1 - The core viewpoint of the news is that Chuangyue Huikang (300451) has been added to the "Alibaba" concept due to its collaborations with Alibaba, Tencent, and related companies in areas such as cloud computing and mobile payments within smart healthcare [1] - The company has other associated concept sectors including AI healthcare, DeepSeek, AI agents, AIGC, data elements, artificial intelligence, Huawei Harmony, Huawei computing power, smart healthcare, Xinchuang, blockchain, family doctors, Internet of Things, DRG-DIP, domestic software, big data, and elderly care [1] - Chuangyue Huikang's main business has shifted from primarily product development and sales to a broader focus on system construction, services, and operations, including smart medical health, Internet healthcare, medical IoT, health big data, smart healthcare solutions, system construction and operation, and innovative operational services [1] Group 2 - For the first three quarters of 2025, Chuangyue Huikang reported a main revenue of 862 million yuan, a year-on-year decrease of 26.26% [2] - The company's net profit attributable to shareholders was -122 million yuan, a year-on-year decline of 331.69%, while the non-recurring net profit was -142 million yuan, down 382.12% [2] - In the third quarter of 2025, the company recorded a single-quarter main revenue of 285 million yuan, a year-on-year decrease of 35.5%, with a net profit attributable to shareholders of -41.67 million yuan, down 264.2% [2] - The company's debt ratio stands at 20.27%, with investment income of 4.44 million yuan, financial expenses of -5.32 million yuan, and a gross profit margin of 49.87% [2]
股票行情快报:创业慧康(300451)10月31日主力资金净卖出1671.89万元
Sou Hu Cai Jing· 2025-10-31 14:41
Core Viewpoint - The stock of Chuangye Huikang (300451) has shown a recent increase in price, but the company is facing significant declines in revenue and profit margins, indicating potential challenges ahead [1][3]. Financial Performance - As of October 31, 2025, Chuangye Huikang's stock closed at 4.76 yuan, up 3.48% with a trading volume of 507,300 shares and a turnover of 239 million yuan [1]. - For the third quarter of 2025, the company reported a main revenue of 285 million yuan, a year-on-year decrease of 35.5%, and a net profit attributable to shareholders of -41.67 million yuan, down 264.2% year-on-year [3]. - The company's total revenue for the first three quarters of 2025 was 862 million yuan, a decline of 26.26% compared to the previous year, with a net profit of -122 million yuan, down 331.69% [3]. Market Position and Ratios - Chuangye Huikang's total market capitalization is 73.74 billion yuan, with a net asset value of 4.375 billion yuan [3]. - The company has a negative price-to-earnings ratio of -45.25 and a price-to-book ratio of 1.71, which is significantly lower than the industry average [3]. - The gross margin stands at 49.87%, which is above the industry average of 43.84%, but the net margin is -12.39%, indicating profitability issues [3]. Investment Sentiment - In the last 90 days, four institutions have rated the stock as a buy, with an average target price of 5.76 yuan [4]. - The recent capital flow data indicates a net outflow of 16.72 million yuan from institutional investors on October 31, 2025, while retail investors saw a net inflow of 15.28 million yuan [1][2].
创业慧康(300451)8月1日主力资金净买入1833.71万元
Sou Hu Cai Jing· 2025-08-04 01:21
Summary of Key Points Core Viewpoint - The stock of Chuangye Huikang (300451) has shown a slight increase, with a closing price of 5.95 yuan on August 1, 2025, reflecting a 2.76% rise, amidst mixed capital flows from different investor groups [1]. Financial Performance - Chuangye Huikang reported a main revenue of 290 million yuan in Q1 2025, a year-on-year decrease of 22.67% - The net profit attributable to shareholders was -15.64 million yuan, down 226.6% year-on-year - The company’s gross profit margin stands at 55.12% [4][5]. Capital Flow Analysis - On August 1, 2025, the net inflow of main funds was 18.34 million yuan, accounting for 3.04% of the total transaction amount - Retail investors experienced a net outflow of 16.92 million yuan, representing 2.8% of the total transaction amount [1][2]. Financing and Margin Trading - On August 1, 2025, the financing buy amounted to 48.18 million yuan, while the financing repayment was 65.73 million yuan, resulting in a net repayment of 17.55 million yuan - The total margin trading balance was 498 million yuan [1][2]. Industry Comparison - Chuangye Huikang's total market value is 9.171 billion yuan, compared to the software development industry average of 12.789 billion yuan - The company has a price-to-earnings ratio of -146.52, significantly lower than the industry average of 70.97 [4][5]. Institutional Ratings - In the last 90 days, three institutions have rated the stock, with two buy ratings and one hold rating - The average target price set by institutions is 6.13 yuan [5].